LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Thomson Reuters and BioCentury NewsMakers in the Biotech Industry Conference on Thursday, September 4, 2008 at 4:00 p.m. (ET) at the Millennium Broadway Hotel in New York.
